To Unlock the Potential of Cannabis, The Industry Needs More Research

A recent spate of vaping-related lung illnesses has lawmakers and health officials calling for more testing of legal cannabis products. But because cannabis is classified as a Schedule I drug by the federal government, states’ hands are tied when it comes to testing. One way to open the door to more cannabis testing is to remove the research restrictions in place due to cannabis having Schedule I designation. Congress declared cannabis a Schedule I drug…


Go to Source

Powered by WPeMatico